Scribe Therapeutics (Series A)
Funding Details
Awarder
Inbox
Date Award
October 7, 2020
Vertical
Molecular Engineering
Funding URL
View Funding Page
Funding Amount
$20,000,000
Company Info
Founders
Benjamin Oakes, Brett Staahl, David Savage, Jennifer Doudna
Market
Genetic Medicine
Location
Alameda, California, USA
Coinvestors
Biogen Idec
Company Description

Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.

Links
WebsiteCrunchbaseLinkedInTwitter
Back to HomeBack to Molecular Engineering DealsView Funding Announcement